May 20, 2026 - ChartAlert®

APOLLOHOSP – Apollo Hospitals Enterprise – Q4 FY26 Financial Results – 20-May-26

Apollo Hospitals’ FY26 delivered 33% PAT on 16% revenue growth, with Digital Health turning profitable — a margin expansion catalyst compressing EV/EBITDA. Net debt/EBITDA ~0.9x, but current borrowings spike and opaque acquisition need scrutiny. FCF ~₹8,937 Mn confirms self‑funding; FY27 watch is debt structure and capex intensity.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 15.8% YoY (₹217,940 Mn → ₹252,285 Mn), with all three core segments contributing — Healthcare Services (+13.6%), Retail Health & Diagnostics (+20.1%), and Digital Health & Pharmacy (+18.9%).
Q4FY26 revenue at ₹66,055 Mn grew 18.1% YoY over Q4FY25 (₹55,922 Mn), maintaining strong sequential momentum.
Digital Health & Pharmacy is now 43% of consolidated revenues, cementing its role as the volume engine.

Bottomline

PAT grew 33.1% YoY (₹15,051 Mn → ₹20,027 Mn), significantly outpacing revenue growth — a clear sign of operating leverage kicking in.
Basic EPS jumped from ₹100.56 to ₹135.04 (+34.3% YoY), reflecting earnings accretion without dilution.
Q4FY26 PAT of ₹5,513 Mn grew 33% YoY over Q4FY25 (₹4,145 Mn), sustaining the annual acceleration trend.

Margins

EBITDA proxy (PBT + Finance costs + D&A): FY26 = ₹26,609 + ₹4,496 + ₹8,761 = ₹39,866 Mn on revenues of ₹252,285 Mn → EBITDA margin ~15.8% vs FY25 (₹20,391 + ₹4,585 + ₹7,575 = ₹32,551 Mn on ₹217,940 Mn) → ~14.9%. Margin expanded ~90 bps YoY.
Net profit margin: FY26 = 7.9% vs FY25 = 6.9% — 100 bps expansion, driven by Digital Health segment swinging to meaningful profitability (₹1,127 Mn → ₹3,987 Mn segment result).
Retail Health & Diagnostics segment result nearly tripled (₹300 Mn → ₹723 Mn), adding further margin uplift.

Growth Trajectory

Three-year compounding is clearly accelerating: PAT grew 33% this year versus revenue growth of 16% — bottomline is finally outrunning topline.
Digital Health segment results surged 254% YoY (₹1,127 Mn → ₹3,987 Mn), signalling a structural shift from investment phase to profit contribution.
Segment result margin for Healthcare Services: FY26 = 24,303/127,501 = 19.1% vs FY25 = 21,295/112,201 = 19.0% — core hospital margins holding steady while adjacencies scale.

BOSCHLTD – Bosch Limited – Q4 FY26 Financial Results – 20-May-26

Bosch India’s FY26 confirms a cash‑rich industrial compounding low‑mid teens revenue, with ~17% underlying earnings growth post divestiture gain. Risks: commodity cost pressures, receivables velocity, and tax normalization. Overcapitalized balance sheet (₹83,797 Mio treasury, negligible debt) makes capital allocation discipline the key re‑rating driver.

1–2 minutes

🔍 Observations

Topline

Revenue grew 10.8% YoY to ₹200,347 Mio in FY26, crossing the ₹200 Bn milestone; Q4FY26 accelerated to 13.3% YoY, signalling momentum building into year-end.
Automotive products — 88.9% of net revenues — drove growth at 14.5% YoY (₹178,074 Mio vs ₹155,489 Mio); Consumer goods grew a modest 6.4%.
“Others” segment revenue collapsed 49.5% YoY (₹8,486 Mio to ₹4,285 Mio), reflecting the deliberate divestiture of specified businesses rather than organic decline.

Bottomline

Reported PAT jumped 37.6% YoY to ₹27,700 Mio, but ₹5,560 Mio in pre-tax exceptional gains (divestiture proceeds) inflate this; adjusted PAT grew ~16.9% to ~₹23,530 Mio.
EPS (basic) rose to ₹940.27 from ₹683.25 — reported basis; underlying earnings quality is solid even after stripping out the exceptional.
Q4FY26 PAT of ₹5,685 Mio grew 2.7% YoY and 6.8% QoQ, a clean quarter with no exceptional items.

Margins

EBITDA margin (excl. exceptional) expanded marginally to 17.5% from 17.3% — a tight band suggesting cost discipline offset input cost pressures.
Automotive EBIT margin held flat at 14.4% YoY despite 14.5% revenue growth — volume-driven profit expansion with no margin dilution.
Q4FY26 EBITDA margin contracted to 16.9% vs 18.0% in Q4FY25, partly from higher raw material costs (Q4 RM+traded goods: ₹35,710 Mio vs ₹30,242 Mio in Q4FY25, +18.1%).

Growth Trajectory

Three-year revenue CAGR context: crossing ₹200 Bn on a consolidated basis reflects steady compounding in the mid-teens in Automotive — structurally tied to India’s vehicle production cycle.
Automotive EBIT grew 13.8% YoY (₹22,467 Mio to ₹25,570 Mio) in line with segment revenue — consistent conversion, no margin surprises.
Consumer goods EBIT grew 7.6% (₹1,130 Mio to ₹1,216 Mio) — low-margin, slow-growth segment; EBIT margin at 6.6%, unchanged from 6.5% prior year.

GRASIM – Grasim Industries – Q4 FY26 Financial Results – 20-May-26

Grasim’s FY26 delivered 32.8% PAT growth, 130 bps EBIT margin expansion, and Building Materials scale milestone. Risks: structural cash consumption, NBFC/HFC growth masking credit risk, and negative FCF. Re‑rating hinges on Building Materials margin inflection, debt trajectory, and NBFC asset quality disclosures alongside consolidated PAT.

1–2 minutes

🔍 Observations

Topline

Consolidated revenue from operations surged 18.2% YoY (₹1,48,478 Cr → ₹1,75,431 Cr), led by Building Materials (+24.3%) and Financial Services (+11.8%) — both structurally large segments with compounding scale.
Q4FY26 revenue hit ₹51,101 Cr, up 15.4% YoY and 15.3% QoQ, suggesting Q4 seasonality tailwinds and demand acceleration in cement/paints.
Building Materials contributed ₹1,01,202 Cr (57.7% of segment revenue) — crossed the ₹1 lakh Cr milestone for the first time, reflecting UltraTech + Birla Opus scale-up.

Bottomline

Net profit jumped 32.8% YoY (₹7,756 Cr → ₹10,300 Cr); Q4FY26 alone delivered ₹3,802 Cr, up 27.9% YoY — strongest quarterly print.
EPS expanded from ₹55.57 to ₹73.21 (basic), a 31.7% YoY jump on a stable share count — purely earnings-driven, not dilution.
Total tax expense rose 35.9% YoY, absorbing some profit upside; effective tax rate held near 28.8% — slightly elevated but not alarming.

Margins

Consolidated EBIT margin (segment EBIT / segment revenue): ₹25,693 Cr on ₹1,77,217 Cr = 14.5% vs 13.2% in FY25 — 130 bps expansion YoY.
Building Materials EBIT grew 36.2% (₹12,012 Cr → ₹16,364 Cr) on 24.3% revenue growth — operating leverage clearly visible; this segment is the primary margin engine.
Net profit margin (PAT / Revenue from Ops): 10,300 / 1,75,431 = 5.87% vs 5.22% in FY25 — 65 bps improvement, meaningful for a conglomerate of this size.

Growth Trajectory

Cellulosic Fibres EBIT: +14.9% YoY (₹1,524 Cr → ₹1,751 Cr) on 7.6% revenue growth — margin improvement driving profitability, not just volume.
Financial Services EBIT: +13.8% YoY (₹4,650 Cr → ₹5,293 Cr) — NBFC/HFC loan book growing, finance costs rising in tandem but EBIT spread holding.
Chemicals EBIT: +16.4% YoY (₹1,208 Cr → ₹1,406 Cr) — steady contributor, not high-growth but consistent.

TDPOWERSYS – TD Power Systems – Q4 FY26 Earnings Call – 15-May-26

TD Power Systems’ topline driven by export demand (AI/data centers, renewables), bottomline supported by margin reversion post-Turkey one-off, and margins stable at 34%+ barring commodity shocks.

1–2 minutes

Also see: TDPOWERSYS – TD Power Systems – Q4 FY26 Financial Results – 14-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

Key Variables: Execution stability, commodity neutrality, order inflow at +20–25% YoY.
Outlook: INR 24B revenue (FY27), 34%+ gross margins, INR 32B capacity by FY28. AI/data center demand sustains growth; large generator ramp-up from Calendar 2028. FX and hedges offset copper spikes.

KAYNES – Kaynes Technology India – Q4 FY26 Earnings Call – 14-May-26

Kaynes Technology’s topline growth hinges on metering execution and OSAT/PCB scale, while margins and cash flows are structurally pressured by working capital and amortization until H2 FY27.

1–2 minutes

Also see: KAYNES – Kaynes Technology India – Q4 FY26 Financial Results – 13-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Metering receivables reduce 70% in 3 quarters, OSAT/PCB at guidance (INR550-700 crore), automotive grows at 10%.
Outcome: Revenue INR4,000-4,200 crore in FY27, EBITDA margins 15-16%, OCF breakeven by Q4 FY27. Diversification offsets cyclical weakness, but execution risks persist.

TVSMOTOR – TVS Motor Company – Q4 FY26 Earnings Call – 13-May-26

TVS Motor’s topline growth hinges on export momentum and EV scaling, while margins depend on commodity offsets and premium mix; structural tailwinds (capacity, R&D, partnerships) outweigh cyclical risks if execution holds.

1–2 minutes

Also see: TVSMOTOR – TVS Motor Company – Q4 FY26 Financial Results – 13-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Commodity inflation at 3–5%, supply chain resolves by H1 FY27, EV penetration at 8–9%, export growth at 15–20%.
Outcome: Revenue grows 10–12% YoY, EBITDA margin sustains at 13%, and EV revenue reaches ~INR 7,000 crore. Capex execution on track; margin stability via price hikes and mix.

TEXRAIL – Texmaco Rail & Engineering – Q4 FY26 Earnings Call – 13-May-26

Texmaco Rail & Engineering/ TEXRAIL’s topline growth hinges on tender execution and export scaling, while margins depend on cost pass-through and mix shift; Texmaco 2.0’s success (defense/AI) is the swing factor for long-term re-rating.

1–2 minutes

Also see: TEXRAIL – Texmaco Rail & Engineering – Q4 FY26 Financial Results – 12-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

Key Variables: (1) Indian Railways tenders materialize in tranches (Q3 FY27), (2) Supply chain normalizes by H2 FY27.
Outlook: Revenue grows 10–15% YoY in FY27 (export orders + private sector), EBITDA margins sustain at 10–11% (cost controls + mix shift). Defense/AI capex begins in FY27, but contribution to FY27 earnings minimal. Net debt/equity remains <0.2.

GRSE – Garden Reach Shipbuilders – Q4 FY26 Earnings Call – 12-May-26

Garden Reach Shipbuilders/ GRSE’s topline growth hinges on NGC/P-17 Bravo timelines and export traction, while margins depend on defense mix and cost controls; base case supports 10–12% EBITDA margins with double-digit revenue growth.

1–2 minutes

Also see: GRSE – Garden Reach Shipbuilders – Q4 FY26 Financial Results – 28-Apr-26

3-Scenario Framework

📊 Base Case (50% Probability)

NGC signed in Q2FY27, P-17 Bravo contract by FY27-end, and 1 export order in FY27. Revenue grows 12–15% CAGR (FY26–28) with EBITDA margins at 10–11%. Order book stabilizes at INR 20,000 crore by FY28, supported by defense RFPs and marginal commercial wins.